Mind Medicine (MindMed) (MNMD) Stock: 1-For-15 Split Goes Into Effect

By Amit Chowdhry ● Aug 29, 2022
  • A 1-for-15 split of Mind Medicine (MindMed) Inc (MNMD) has gone into effect. These are the details.

Mind Medicine (MindMed) Inc. (MNMD) – a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders – announced that its previously announced 1-for-15 reverse share split of the company’s common shares became effective after the close of markets on August 26, 2022, with trading starting on a split-adjusted basis on the Nasdaq and the Neo Exchange at market open on August 29, 2022.

The common shares will continue to trade under the symbols “MNMD” on the Nasdaq and “MMED” on the NEO but are assigned CUSIP number 60255C885 and ISIN number CA60255C8850 following the reverse share split.